Berberine 관련 인슐린 저항성
A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.
결론
Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.
Key Study Findings
대상 집단: Women with PCOS and insulin resistance
대상 집단: None
대상 집단: Obese population (herbal medicine review)
대상 집단: Healthy individuals
대상 집단: None
대상 집단: HFD-induced NAFLD rat model
Key Statistics
27
연구
2500
참여자
Positive
등급
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 500 mg 2-3x/day with meals
- starting:
- 500 mg/day and titrate
- metabolicsupport:
- 1,000-1,500 mg/day
상한량: 1,500 mg/day; GI side effects limit intake; potential drug interactions
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Various herbal medicines | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
권장 복용 시간: With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)
Safety & Side Effects
보고된 부작용
- ⚠ Diarrhea
- ⚠ Constipation
- ⚠ Flatulence
- ⚠ Abdominal pain
- ⚠ Potential hypoglycemia (when combined with diabetes medications)
알려진 상호작용
- ● Diabetes medications (may potentiate — hypoglycemia risk)
- ● CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
- ● CYP2D6 substrates
- ● Cyclosporine
- ● Metformin (additive effects)
일일 최대 섭취 허용량: 1,500 mg/day; GI side effects limit intake; potential drug interactions
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Berberine help with 인슐린 저항성?
How much Berberine should I take for 인슐린 저항성?
Are there side effects of Berberine?
How strong is the evidence for Berberine and 인슐린 저항성?
Related Evidence
관련 다른 성분: 인슐린 저항성
Berberine 다른 건강 상태에 대한 근거
References
- [1] Daniela Ciobârcă et al.. Pharmaceuticals (Basel). 2025. Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. doi:10.3390/ph18020279 PubMed
- [2] Lin Yin et al.. Front Nutr. 2025. The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in polycystic ovary syndrome. doi:10.3389/fnut.2025.1700612 PubMed
- [3] Qiao Zhang et al.. J Ethnopharmacol. 2023. Role of herbal medicine and gut microbiota in the prevention and treatment of obesity. doi:10.1016/j.jep.2022.116127 PubMed
- [4] Ayoub Amssayef et al.. Curr Pharm Des. 2023. Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review. doi:10.2174/0113816128270340231121043038 PubMed
- [5] Ting-Wei Zhu et al.. Clin Exp Pharmacol Physiol. 2023. Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome. doi:10.1111/1440-1681.13814 PubMed
- [6] Mingyue Zhong et al.. Food Funct. 2022. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. doi:10.1039/d2fo01009g PubMed
- [7] Shi-Jun Yue et al.. Am J Physiol Endocrinol Metab. 2019. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. doi:10.1152/ajpendo.00256.2018 PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.